Fulvestrant-d3
Share product
- structure.search.product.name Fulvestrant-d3
- Product Code: TRC-F862502
- Brand: TRC
Product Overview
Product Code
TRC-F862502
Product Format
Neat
Molecular Formula
C32H44D3F5O3S
Molecular Weight
609.79
API Family
FulvestrantProduct Categories
Pharmaceutical Reference Standards, TRC, Chiral Molecules , Agonist & antagonist analogues, Stable isotopes, Stable Isotope Labelled Analytical Standards, API Reference Standards & Research Materials
Unlabelled CAS Number
Purity
>95% (HPLC)
Drug Type
Hormones & Derivatives
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
Email download link
{{ errors[0] }}
{{ errors[0] }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors[0] }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors[0] }}
{{ errors[0] }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
Fulvestrant-d3
Molecular Formula
C32H44D3F5O3S
Molecular Weight
609.79
SMILES
OC1=CC(C[C@@H](CCCCCCCCCS(CCCC(F)(F)C(F)(F)F)=O)[C@]2([H])[C@]3([H])CC[C@@]4(C)[C@@]2([H])CC([2H])([2H])[C@]4([2H])O)=C3C=C1
InChI
InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1/i14D2,28D
Unlabelled CAS Number
129453-61-8
SIL Type
Deuterium
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
Stable Isotope Labelled; API
Product Format
Neat
API Family
Purity
>95% (HPLC)
Product Description
A novel labelled steroidal estrogen antagonist reported to lack any partial agonist activity. Antineoplastic (hormonal).
References: Wakeling, A.E., et al.: Cancer Res., 51, 3867 (1991), Howell, A., et al.: Br. J. Cancer, 74, 300 (1996), Robertson, J.F., et al.: Cancer Res., 61, 6739 (2001),
{{ errors[0] }}